Restaging breast cancer after somatostatin receptor scintigraphy with [In-111-DTPA-Phe-1]-octreotide

被引：0
|
作者：
Giannakenas, C
Tzorakoleftherakis, E
Kalofonos, HP
Petsas, T
Vassilakos, PJ
机构：
[1] UNIV PATRAS,REG HOSP,DEPT NUCL MED,PATRAS,GREECE
[2] UNIV PATRAS,REG HOSP,DEPT SURG,PATRAS,GREECE
[3] UNIV PATRAS,REG HOSP,DEPT ONCOL,PATRAS,GREECE
[4] UNIV PATRAS,REG HOSP,DEPT RADIOL,PATRAS,GREECE
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [31] Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy -: Reply
    Smith-Jones, PM
    Havlik, E
    Kurtaran, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (04): : 443 - 444
  • [32] 111In-DTPA-D-Phe-1-Asp0-D-Phe1-octreotide exhibits higher tumor accumulation and lower renal radioactivity than 111In-DTPA-D-Phe1-octreotide
    Oshima, Nobuhiro
    Akizawa, Hiromichi
    Kitaura, Hirotake
    Kawashima, Hidekazu
    Zhao, Songji
    Zhao, Yan
    Nishijima, Ken-ichi
    Kitamura, Yoji
    Arano, Yasushi
    Kuge, Yuji
    Ohkura, Kazue
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 54 : 18 - 26
  • [33] Scintigraphic imaging of sarcomatous tumors with [111In-DTPA-Phe-1]-octreotide
    Giannakenas, C
    Kalofonos, HP
    Apostolopoulos, D
    Petsas, T
    Kalogeropoulou, C
    Tzorakelefterakis, E
    Skopa, CD
    Vassilakos, PJ
    ONCOLOGY, 2000, 58 (01) : 18 - 24
  • [34] Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo
    Akizawa, H
    Arano, Y
    Uezono, T
    Ono, M
    Fujioka, Y
    Uehara, T
    Yokoyama, A
    Akaji, K
    Kiso, Y
    Koizumi, M
    Saji, H
    BIOCONJUGATE CHEMISTRY, 1998, 9 (06) : 662 - 670
  • [35] 111In-DTPA-D-Phe1-octreotide的动物实验
    王凡
    陈方
    肖伦
    樊红强
    金小海
    王翌善
    陈大明
    白宏升
    李家秀
    刘琳
    核技术, 1998, (05) : 293 - 296
  • [36] [IN-111-DTPA-D-PHE1]-OCTREOTIDE, A POTENTIAL RADIOPHARMACEUTICAL FOR IMAGING OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS - SYNTHESIS, RADIOLABELING AND INVITRO VALIDATION
    BAKKER, WH
    ALBERT, R
    BRUNS, C
    BREEMAN, WAP
    HOFLAND, LJ
    MARBACH, P
    PLESS, J
    PRALET, D
    STOLZ, B
    KOPER, JW
    LAMBERTS, SWJ
    VISSER, TJ
    KRENNING, EP
    LIFE SCIENCES, 1991, 49 (22) : 1583 - 1591
  • [37] Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe(1)-octreotide
    Wangberg, B
    ForssellAronsson, E
    Tisell, LE
    Nilsson, O
    Fjalling, M
    Ahlman, H
    BRITISH JOURNAL OF CANCER, 1996, 73 (06) : 770 - 775
  • [38] METASTATIC HORMONE-REFRACTORY PROSTATIC ADENOCARCINOMA EXPRESSES SOMATOSTATIN RECEPTORS AND IS VISUALIZED IN-VIVO BY [IN-111]-LABELED DTPA-D-[PHE(1)]-OCTREOTIDE SCINTIGRAPHY
    NILSSON, S
    REUBI, JC
    KALKNER, KM
    LAISSUE, JA
    HORISBERGER, U
    OLERUD, C
    WESTLIN, JE
    CANCER RESEARCH, 1995, 55 (23) : S5805 - S5810
  • [39] Peptide receptor radionuclide therapy with [indium-111-DTPA-D-PHE]-octreotide (OC).
    Krenning, EP
    Valkema, R
    Kooij, PPM
    Breeman, WAP
    Bakker, WH
    deHerder, WW
    vanEijck, CHJ
    Kwekkeboom, DJ
    deJong, M
    Pauwels, S
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 167 - 167
  • [40] Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer
    Skånberg, J
    Ahlman, H
    Benjegård, SA
    Fjälling, M
    Forssell-Aronsson, EB
    Hashemi, SH
    Nilsson, O
    Suurkula, M
    Jansson, S
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (02) : 101 - 111
12345